Evidence mapPaperPMID 41855082Full record

ArticleJournal of diabetes investigation2026

Evaluation of %CV and average glucose derived from pre- and postprandial 6-point glucose measurements for assessing hypoglycemia risk.

Rika Soga, Keiichi Torimoto, Fumi Uemura, Yosuke Okada, Shingo Nakayamada

Abstract read
In one paragraph

Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rika SogaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Keiichi TorimotoFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Fumi UemuraFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Yosuke OkadaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.ORCID https://orcid.org/0000-0002-6327-8179
Shingo NakayamadaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionThis study determined the usefulness of coefficient of variation (%CV) and average glucose (AG) from 6-point pre- and postprandial blood glucose measurements in assessing hypoglycemia risk in type 2 diabetes. MATERIALS AND

methodsWe retrospectively analyzed 24-h continuous glucose monitoring data of 233 patients treated with sulfonylureas or insulin. Hypoglycemia was defined as level 1 (<70 mg/dL) or level 2 (<54 mg/dL).

resultsThe 6-point AG and %CV were 182.9 mg/dL and 23.9%, respectively, for all patients, whereas they were 155.8 mg/dL and 29.8% in patients with level 1 hypoglycemia. Receiver operating characteristic analysis determined cutoff values of 167.7 mg/dL for AG and 21.6% for %CV for predicting level 1 hypoglycemia. Using these thresholds as hypoglycemia risk factors, the incidence was evaluated in the three groups according to the number of risk factors. The incidence of both levels 1 and 2 hypoglycemia increased significantly with increase in the number of risk factors. Compared to risk factor-free patients, the odds ratios for level 1 hypoglycemia were 12.1 and 1.4 in those with two and one risk factor, respectively.

conclusionsOur findings suggest that the AG and %CV derived from 6-point glucose measurements can be potentially useful for detecting hypoglycemia risk.

Indexed as

BiomarkersBlood GlucoseDiabetes Mellitus, Type 2HypoglycemiaHypoglycemic AgentsPostprandial PeriodAgedContinuous Glucose MonitoringFemaleHumansInsulinMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsBiomarkersBlood GlucoseHypoglycemic AgentsInsulinSulfonylurea CompoundsContinuous glucose monitoringHypoglycemiaSelf‐monitoring of blood glucose

Identifiers

PMID41855082
PMCPMC13137276

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.